Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Treasury Shares (2016 - 2026)

Option Care Health (OPCH) has disclosed Treasury Shares for 18 consecutive years, with $835.7 million as the latest value for Q1 2026.

  • For Q1 2026, Treasury Shares rose 37.3% year-over-year to $835.7 million; the TTM value through Mar 2026 reached $835.7 million, up 37.3%, while the annual FY2025 figure was $818.2 million, 61.19% up from the prior year.
  • Treasury Shares hit $529000.0 in Q1 2026 for Option Care Health, down from $27.7 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $27.7 million in Q4 2025 and bottomed at $383722.0 in Q1 2022.
  • Average Treasury Shares over 5 years is $9.9 million, with a median of $6.9 million recorded in 2023.
  • Year-over-year, Treasury Shares changed 0.0% in 2022 and then soared 10516.19% in 2023.
  • Option Care Health's Treasury Shares stood at $2.4 million in 2022, then skyrocketed by 10516.19% to $255.1 million in 2023, then skyrocketed by 98.97% to $507.6 million in 2024, then surged by 61.19% to $818.2 million in 2025, then rose by 2.14% to $835.7 million in 2026.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $835.7 million, $818.2 million, and $722.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.